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Introduction: Less than 1 percent of patients with pharmaco-
resistant epilepsy are referred to epilepsy centers at an average
of 22 years after onset. Surgery, if properly performed,  has pro-
ved superior over medicamentous treatment of pharmacoresi-
stant mesial temporal lobe epilepsy (MTLE). Surgery should
be considered fairly early in the course of pharmacoresistant
MTLE treatment.
Patients and methods: 29 patients with pharmacoresistant
MTLE due to hippocampal sclerosis were operated on at the
Department of Neurosurgery University Hospital „Sestre mi-
losrdnice“ from November 2009. until May 2013. All patients
experienced refractory complex partial seizures on monthly
basis despite the optimized dosis of 2 or 3 antiepileptic drugs.
Preoperative evaluation included a detailed clinical history ta-
king, continuous videoEEG monitoring lasting from 2 to 14
days, high resolution 1,5 T or 3T magnetic resonance (MR)
including T1-WI, T2-WI and FLAIR images, neuropsyhologi-
cal examination, interictal PET/CT brain scan and visual field
examination. Selective amygdalohippocampectomy (SAH) via
subtemporal approach was performed in 27 patients and stan-
dard anterior temporal lobectomy and amygdalohippocampec-
tomy was performed in two patients. One patient with selective
AH experienced temporal intracerebral hemorrhage with tran-
sient sensory dysphasia and achieved full recovery at three
months postoperatively.  Follow-up ranged from two months to
43 months. Patients were classified according to the ILAE and
Engel postsurgical assessment. 
Results: 7 out of 29 patients were followed for more than three
years. 17 out of 29 patients were followed more than two years
and 5 patients less than a year. Out of 24 patients with a follow
up more than two years, 21 patients (87%) are completely sei-
zure and aura free (ILAE=1; Engel =1). 
Conclusion: We presented results of the epilepsy surgery pro-
gramme at our Institution. Despite the short term follow-up
we feel encouraged with the surgical and seizure outcome and
find it comparable with other published series. 
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